Windward Bio Group AG WWB
24.48 USD -5.56 (-18.51%)
As ofNov 17, 2026, 2:08 PM EST
21.38 Day range 29.67
18.35 52-week range 33.99
- YTD
- -14.11%
- 1 year
- -14.11%
News
globenewswire.com Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters' Option to Purchase Additional Shares BASEL, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG ("Windward") (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for…
benzinga.com Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Session U.S. stock futures fell as Aclaris plunged 21% after its dermatitis trial failed; Summit and other stocks also dropped in premarket trading.
prnewswire.com Innovative Immunology Biotech Windward Bio Lists on Nasdaq /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on
globenewswire.com Windward Bio Announces Pricing of Initial Public Offering BASEL, Switzerland, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG (“Windward”) (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for…
